Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab

Abstract

Untreated, abnormal periventricular gradients worsen with time, but appear reversible with peripheral immunotherapy. Baseline gradients - but not lesion loads or brain volumes - may predict on-treatment relapses. Larger confirmatory studies are required.